Literature DB >> 2469374

Diabetes as a risk factor for retinal neovascularization in retinal vein occlusion.

R L Funderburk1, E B Feinberg.   

Abstract

We evaluated a series of patients with retinal vein occlusive disease to determine whether diabetic patients with vein occlusions developed retinal neovascularization more frequently than did nondiabetics. Retinal neovascularization occurred in 68.8% of diabetics after central retinal vein occlusion compared with 27.8% of nondiabetics. Diabetics with branch retinal vein occlusions showed no greater likelihood for subsequent retinal neovascularization than did nondiabetics.

Entities:  

Mesh:

Year:  1989        PMID: 2469374

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  5 in total

1.  Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion.

Authors:  J G Santiago; S Walia; J K Sun; J D Cavallerano; Z A Haddad; L P Aiello; P S Silva
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

Review 2.  Ocular associations of diabetes other than diabetic retinopathy.

Authors:  V Swetha E Jeganathan; Jie Jin Wang; Tien Yin Wong
Journal:  Diabetes Care       Date:  2008-09       Impact factor: 19.112

3.  Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion.

Authors:  Shiu-Chen Wu; Yung-Sung Lee; Wei-Chi Wu; Shirley H L Chang
Journal:  BMC Ophthalmol       Date:  2016-05-31       Impact factor: 2.209

4.  Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion.

Authors:  Andrea Szigeti; Mónika Ecsedy; Miklós Schneider; Lilla Lénárt; Balázs Lesch; Zoltán Zsolt Nagy; Andrea Fekete; Zsuzsanna Récsán
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

5.  Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus.

Authors:  Taraprasad Das; Umesh C Behera; Harsha Bhattacharjee; Clare Gilbert; G V S Murthy; Ramachandran Rajalakshmi; Hira B Pant; Rajan Shukla
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.